At the CTGCT Centre of Excellence, we will develop gene and cell therapy technologies, and work to bring advanced medicines to clinical trials for diseases for which we do not yet have effective treatments. This is to improve survival possibilities and quality of life for patients suffering rare diseases or cancers.

Project: 101059842 - CTGCT - HORIZON-WIDERA-2022                                                                                                                               

Co-funded by the European Union, this project has received funding from Horizon Europe (grant agreement No. 101059842), the UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee (grant number 10069462) and European Regional Development Fund EU under Slovenia’s Cohesion Policy Programme 2021-2027 (grant agreement No. C3360-25-952005). Views and opinions expressed are of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Commission nor the granting authority can be held responsible for them.

CTGCT

Org chart

Teams

Offices